Indraprastha Medical Corporation Shareholders Approve Independent Director Appointments Through Postal Ballot
Indraprastha Medical Corporation Limited successfully completed its postal ballot voting on 20th March, 2026, with shareholders approving all four special resolutions for independent director appointments and re-appointments. The remote e-voting process saw 455 members vote representing 2,33,83,859 shares, with approval rates ranging from 94.09% to 99.94% across the four resolutions. The results strengthen the company's board composition with experienced independent directors for five-year terms.

*this image is generated using AI for illustrative purposes only.
Indraprastha Medical Corporation Limited has successfully concluded its postal ballot voting process, with shareholders approving all four special resolutions related to independent director appointments and re-appointments. The remote e-voting period ended on 20th March, 2026, at 5:00 p.m. (IST), with results announced on 21st March, 2026.
Postal Ballot Overview
The postal ballot process was conducted entirely through remote e-voting, facilitated by National Securities Depository Limited (NSDL). The company had 82,949 shareholders on the record date of 13th February, 2026, with postal ballot notices sent electronically to 74,385 shareholders whose email addresses were registered with the company or depositories.
| Voting Details: | Information |
|---|---|
| Record Date: | 13th February, 2026 |
| Total Shareholders: | 82,949 |
| E-voting Period: | 19th February to 20th March, 2026 |
| Scrutinizer: | CS Baldev Singh Kashtwal |
| Participating Members: | 455 |
| Total Shares Voted: | 2,33,83,859 |
Director Appointments and Re-appointments
The postal ballot covered four special resolutions, all of which were approved with requisite majority. Three resolutions involved re-appointments of existing independent directors for second terms, while one resolution concerned the appointment of a new independent director.
Resolution Results
| Resolution | Director Name (DIN) | Votes in Favour | Votes Against | Approval % |
|---|---|---|---|---|
| Resolution 1: | Mr. Salil Singhal (00006629) | 2,33,69,360 | 14,499 | 99.94% |
| Resolution 2: | Ms. Vineeta Rai (07013113) | 2,20,01,841 | 13,81,975 | 94.09% |
| Resolution 3: | Ms. Madhumita Ganguli (00676830) | 2,22,13,255 | 11,70,604 | 94.99% |
| Resolution 4: | Mr. Harsh Pati Singhania (00086742) | 2,32,46,634 | 1,37,225 | 99.41% |
Voting Participation Analysis
The voting process demonstrated strong participation across different shareholder categories. Promoter and promoter group shareholders showed unanimous support for all resolutions, voting 21,442,500 shares in favour across all four resolutions with zero opposition votes.
Shareholder Category Breakdown
- Promoter and Promoter Group: Held 46,753,000 shares with 45.86% voting participation
- Public Institutions: Held 2,901,585 shares with 48.03% voting participation
- Public Non-Institutions: Held 42,018,415 shares with 1.30% voting participation
The overall voting participation stood at 25.51% of outstanding shares, with 455 members casting their votes electronically. No invalid votes were recorded during the process.
Regulatory Compliance and Process
The postal ballot was conducted in compliance with Section 108 and 110 of the Companies Act, 2013, and Rules 20 and 22 of the Companies (Management and Administration) Rules, 2014. CS Baldev Singh Kashtwal served as the scrutinizer, ensuring fair and transparent voting process.
The company published advertisements in Financial Express (English) and Jansatta (Hindi) newspapers on 20th February, 2026, as required under regulatory provisions. The voting results and scrutinizer's report have been made available on the company's website and NSDL's e-voting portal.
Board Composition Enhancement
With the approval of these resolutions, the company has strengthened its board composition with experienced independent directors. The re-appointments ensure continuity in governance, while the new appointment of Mr. Harsh Pati Singhania brings additional expertise to the board. All appointments are for five-year terms, with specific commencement dates ranging from February to June 2026.
Historical Stock Returns for Indraprastha Medical Corporation
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.03% | -1.37% | -0.61% | -12.27% | +1.68% | +613.57% |
How will the strengthened board composition with new independent directors impact Indraprastha Medical Corporation's strategic initiatives and expansion plans in the healthcare sector?
What specific expertise does Mr. Harsh Pati Singhania bring to the board that could influence the company's future business direction or market positioning?
Will the enhanced governance structure lead to improved ESG ratings or attract institutional investors to increase their stake in the company?































